North America Antibody Drug Conjugates Market to Lead Global Growth Through 2031
The growing burden of cancer across North America is increasing demand for advanced targeted treatment options. Healthcare providers are exploring antibody-drug conjugates as part of the evolving landscape of precision oncology and specialized cancer care. Market Overview The Antibody Drug Conjugates Market is projected to reach US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...
0 Σχόλια 0 Μοιράστηκε 21 Views 0 Προεπισκόπηση